Neural Analytics touts 95% accuracy for TCD platform in Expedite trial Mass Device By John Harbison|2017-05-24T07:31:29-08:00May 24, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Neural Analytics touts 95% accuracy for TCD platform in Expedite trial Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
